BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26163925)

  • 1. The weight of obesity on the human immune response to vaccination.
    Painter SD; Ovsyannikova IG; Poland GA
    Vaccine; 2015 Aug; 33(36):4422-9. PubMed ID: 26163925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.
    Cheng DR; Barton R; Greenway A; Crawford NW
    Expert Rev Vaccines; 2016 Dec; 15(12):1567-1574. PubMed ID: 27216827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity: impact of infections and response to vaccines.
    Tagliabue C; Principi N; Giavoli C; Esposito S
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):325-31. PubMed ID: 26718941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine administration in children with chronic kidney disease.
    Esposito S; Mastrolia MV; Prada E; Pietrasanta C; Principi N
    Vaccine; 2014 Nov; 32(49):6601-6. PubMed ID: 25275950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surveillance in assuring mutual protection for vaccine-preventable diseases.
    Lopalco PL
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S85-S88. PubMed ID: 27476865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IMMUNIZATIONS IN IMMUNOCOMPROMISED HOSTS--PRINCIPLES AND UPDATED RECOMMENDATIONS].
    Hershman-Sarafov M; Potasman I
    Harefuah; 2015 Dec; 154(12):786-90, 804, 803. PubMed ID: 26897782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination issues in patients with chronic kidney disease.
    Mathew R; Mason D; Kennedy JS
    Expert Rev Vaccines; 2014 Feb; 13(2):285-98. PubMed ID: 24405403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
    Grenfell RF; Shollenberger LM; Samli EF; Harn DA
    Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult immunization in India: Importance and recommendations.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2015; 11(9):2180-2. PubMed ID: 25483654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of Vaccination.
    Zepp F
    Methods Mol Biol; 2016; 1403():57-84. PubMed ID: 27076125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in vaccine response in normal populations.
    Ovsyannikova IG; Jacobson RM; Poland GA
    Pharmacogenomics; 2004 Jun; 5(4):417-27. PubMed ID: 15165177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-preventable diseases in Europe: where do we stand?
    Wicker S; Maltezou HC
    Expert Rev Vaccines; 2014 Aug; 13(8):979-87. PubMed ID: 24958075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary vaccine failure to routine vaccines: Why and what to do?
    Wiedermann U; Garner-Spitzer E; Wagner A
    Hum Vaccin Immunother; 2016; 12(1):239-43. PubMed ID: 26836329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of children with secondary immunodeficiency.
    Esposito S; Prada E; Lelii M; Castellazzi L
    Hum Vaccin Immunother; 2015; 11(11):2564-70. PubMed ID: 26176360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic plant-based oral vaccines.
    Lugade AA; Kalathil S; Heald JL; Thanavala Y
    Immunol Invest; 2010; 39(4-5):468-82. PubMed ID: 20450287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of preterm infants.
    Gagneur A; Pinquier D; Quach C
    Hum Vaccin Immunother; 2015; 11(11):2556-63. PubMed ID: 26291883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.